World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
26683
World Ranking
17910
National Ranking
40

Glenda Gray publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Glenda Gray sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 461 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Glenda Gray D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Glenda Gray sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Glenda Gray is affiliated with the South African Medical Research Council in South Africa and has a significant body of work primarily within the field of Medicine. Their research spans multiple subfields including Infectious Diseases, Epidemiology, Virology, Health, and Molecular Biology. The main topics addressed in their work include SARS-CoV-2 and COVID-19 research, HIV/AIDS research and interventions, HIV research and treatment, vaccine coverage and hesitancy, COVID-19 clinical research studies, adolescent sexual and reproductive health, and vaccines and immunoinformatics approaches.

The scientist has contributed to various frequent publication venues, reflecting their active engagement with both specialized and broad scientific communities. These venues include bioRxiv (Cold Spring Harbor Laboratory), South African Medical Journal, UNC Libraries, New England Journal of Medicine, and Scientific Reports.

Among their recent papers are several influential works:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • T cell responses to SARS-CoV-2 spike cross-recognize Omicron, 2022, Nature
  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition, 2021, New England Journal of Medicine
  • COVID-19 in Africa: care and protection for frontline healthcare workers, 2020, Globalization and Health
  • Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa, 2021, International Journal of Infectious Diseases

Glenda Gray has collaborated extensively with several researchers, with notable frequent coauthors including Linda-Gail Bekker, Lawrence Corey, Nigel Garrett, James G. Kublin, and Peter B. Gilbert. These collaborations indicate strong connections within the fields of infectious disease research and clinical studies.

Their research contributions are built on a foundation of investigating vaccine efficacy, HIV treatment innovations, and COVID-19 disease dynamics, highlighting a career deeply involved in addressing public health challenges through clinical and molecular research methodologies.

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

    C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret

  • COVID-19 in Africa: care and protection for frontline healthcare workers.

    Matthew F. Chersich;Glenda Gray;Lee Fairlie;Quentin Eichbaum;Quentin Eichbaum

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

    Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard

  • New Regimens to Prevent Tuberculosis in Adults with HIV Infection

    Neil A. Martinson;Grace L. Barnes;Lawrence H. Moulton;Reginah Msandiwa

  • Prevalence and Patterns of Gender-based Violence and Revictimization among Women Attending Antenatal Clinics in Soweto, South Africa

    Kristin L. Dunkle;Rachel K. Jewkes;Heather C. Brown;Mieko Yoshihama

  • International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations

    Dan H. Barouch;Dan H. Barouch;Sandra V. Kik;Gerrit J. Weverling;Rebecca Dilan

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study

    Michael Sweat;Stephen Morin;David Celentano;Marta Mulawa

  • Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

    Jonathan E Golub;Paul Pronyk;Paul Pronyk;Lerato Mohapi;Nkeko Thsabangu

  • Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

    Karin Nielsen-Saines;D. Heather Watts;Valdilea G. Veloso;Yvonne J. Bryson

  • Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated

    Jeffrey A. Johnson;Jin Fen Li;Lynn Morris;Neil Martinson

  • Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load

    Agatha Masemola;Tumelo Mashishi;Greg Khoury;Phineas Mohube

  • Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.

    Glenda Gray;Susan Buchbinder;Ann Duerr

  • The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.

    Amalia Rodriguez-French;Jack Boghossian;Glenda E Gray;Jeffrey P Nadler

  • Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

    Jairam R Lingappa;Jared M Baeten;Anna Wald;James P Hughes

  • Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa

    Milly Marston;Renaud Becquet;Renaud Becquet;Basia Zaba;Lawrence H. Moulton

  • Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.

    Timothy B. Hallett;Jared M. Baeten;Renee Heffron;Ruanne Barnabas

  • Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk

    Jairam R. Lingappa;James P. Hughes;Richard S. Wang;Jared M. Baeten

Frequent Co-Authors

Janan Dietrich
Janan Dietrich South African Medical Research Council
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
James G. Kublin
James G. Kublin Fred Hutchinson Cancer Research Center
Lynn Morris
Lynn Morris University of the Witwatersrand
Angela Kaida
Angela Kaida Simon Fraser University
Helen Rees
Helen Rees University of the Witwatersrand
Linda Richter
Linda Richter University of the Witwatersrand
M. Juliana McElrath
M. Juliana McElrath University of Washington
Robert S. Hogg
Robert S. Hogg Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their medical education, numerous online degree options and career pathways are available across the healthcare spectrum. If you’re looking to grow your nursing expertise quickly, consider accelerated dnp programs, which allow you to earn your doctorate in nursing at a faster pace than traditional paths.

Budget-conscious students might look into affordable dnp programs, focusing on courses that combine quality education with cost-effectiveness. Practical nursing candidates can opt for fast track lpn programs online, which help you enter the workforce swiftly or continue your studies toward higher qualifications without delay.

Registered nurses interested in mental health specialization can pursue bsn to np programs online focused specifically on psychiatric and mental health, setting the stage for advanced practice roles in this growing field. Exploring these programs can open diverse and flexible opportunities within the U.S. healthcare system.

Best Scientists Citing Glenda Gray

Trending Scientists

Recently Published Articles